Notice2021-20802
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 24, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on November 8, 2021. The topic for this meeting will be "Evolving Concepts in the Assessment and Management of Hypoglycemia." The meeting is open to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 183 (Friday, September 24, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 183 (Friday, September 24, 2021)]
[Notices]
[Page 53079]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-20802]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on November 8, 2021. The topic for this
meeting will be ``Evolving Concepts in the Assessment and Management of
Hypoglycemia.'' The meeting is open to the public.
DATES: The meeting will be held on November 8, 2021 from 12:00 p.m. to
3:00 p.m. EDT.
ADDRESSES: The meeting will be held via the Zoom online video
conferencing platform. For details, and to register, please contact
<a href="/cdn-cgi/l/email-protection#c6a2abafa5a586aba7afaae8a8afaee8a1a9b0"><span class="__cf_email__" data-cfemail="85e1e8ece6e6c5e8e4ece9abebecedabe2eaf3">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, including a draft agenda, which will be posted when
available, see the DMICC website, <a href="http://www.diabetescommittee.gov">www.diabetescommittee.gov</a>, or contact
Dr. William Cefalu, Executive Secretary of the Diabetes Mellitus
Interagency Coordinating Committee, National Institute of Diabetes and
Digestive and Kidney Diseases, 6707 Democracy Boulevard, Democracy 2,
Room 6037, Bethesda, MD 20892, telephone: 301-435-1011; email:
<a href="/cdn-cgi/l/email-protection#d7b3babeb4b497bab6bebbf9b9bebff9b0b8a1"><span class="__cf_email__" data-cfemail="0f6b62666c6c4f626e66632161666721686079">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In accordance with 42 U.S. Code Sec. 285c-
3, the DMICC, chaired by the National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) comprising members of the
Department of Health and Human Services and other federal agencies that
support diabetes-related activities, facilitates cooperation,
communication, and collaboration on diabetes among government entities.
DMICC meetings, held several times a year, provide an opportunity for
Committee members to learn about and discuss current and future
diabetes programs in DMICC member organizations and to identify
opportunities for collaboration. The November 8, 2021 DMICC meeting
will focus on ``Evolving Concepts in the Assessment and Management of
Hypoglycemia.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 5 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC website, <a href="http://www.diabetescommittee.gov">www.diabetescommittee.gov</a>.
Dated: September 21, 2021.
Bruce Tibor Roberts,
Health Science Policy Analyst, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2021-20802 Filed 9-23-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 24, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.